[LXRX] YoY Quarter Result on 30-Sep-2017 [#Q3]

Stock
[LXRX] Lexicon Pharmaceuticals, Inc.
Announcement Date
08-Nov-2017
Financial Year
2017
Quarter
30-Sep-2017 [#Q3]
Profit Trend
QoQ- 12.37%
YoY- 14.70%
Quarter Report
LXRX's Result
LXRX's Financial Summary
View:
Show?
Quarter Result
30/09/20 30/09/19 30/09/18 30/09/17 30/09/16 30/09/15 30/09/14 CAGR
Revenue 6,634 294,448 6,856 26,942 27,717 566 419 58.39%
PBT 82,603 220,072 -27,512 -30,722 -36,015 -35,282 -40,498 -
Tax 4,118 -6,014 783 2,034 1,135 1,627 205 64.80%
NP 82,603 226,086 -27,512 -30,722 -36,015 -35,282 -40,498 -
Tax Rate -4.99% 2.73% - - - - - -
Total Cost -75,969 68,362 34,368 57,664 63,732 35,848 40,917 -
Ratio Analysis
30/09/20 30/09/19 30/09/18 30/09/17 30/09/16 30/09/15 30/09/14 CAGR
NP Margin 1,245.15 76.78 -401.28 -114.03 -129.94 -6,233.57 -9,665.39 -
Per Share
30/09/20 30/09/19 30/09/18 30/09/17 30/09/16 30/09/15 30/09/14 CAGR
EPS 0.77 2.13 -0.26 -0.29 -0.35 -0.34 -0.55 -
EPS Diluted 0.71 1.95 -0.26 -0.29 -0.35 -0.34 -0.55 -

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.